Park Medi World profit and loss

Latest FY26

Revenue: ₹1,679cr
EBITDA: ₹444cr
Net profit: ₹274cr
EPS: ₹6.87

₹ crore except per share

Tap a line for its trend	FY26Mar 2026

Expenses
	1,679
	31.6
	1,711
	295
	0.7
	323
	58.9
	62.5
	616
	1,356
	444
	382
Profit
	355
	355
	82.5
	−1.5
	81.0
	274
	274
	1.0
	275
	258
	15.4
Per share
	₹6.87
	₹6.87
Other comprehensive income — detail
	1.0
	1.3
	0.3
	259
	15.5
Per share — as-filed variants
	₹6.87
	₹6.87
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	1,384
	82.4%
Adjusted (ex-exceptional items) — derived
	355
	274
	₹6.87

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

PARKHOSPS₹221.25

Park Medi World Ltd.

· Pharma & Health

Annual Quarterly₹ CrorePeersMAXHEALTH FORTIS MEDANTA METROPOLIS MARKSANS RUBICON JLHL SHILPAMEDMcap ₹9,556 Cr

View

	In ₹ Crore except Per Share 12 Months Ending	FY26 31/03/2026
	Revenue from Operations	1,679.4
	Other Income	31.6
	Total Income	1,711.0
	Expenses
	+ Cost of Materials Consumed	295.1
	+ Changes in Inventories	0.7
	+ Employee Benefit Expense	323.4
	+ Finance Costs	58.9
	+ Depreciation & Amortisation	62.5
	+ Other Expenses	615.8
	Total Expenses	1,356.4
	EBITDA	444.3
	EBIT	381.9
	Profit
	PBT before Exceptional Items	354.6
	Pretax Income	354.6
	+ Current Tax	82.5
	+ Deferred Tax	-1.5
	Tax Expense	81.0
	Net Income	273.6
	+ Net Income — Continuing Ops	273.6
	+ Other Comprehensive Income	1.0
	Total Comprehensive Income	274.5
	Net Income to Common	258.1
	Minority Interest	15.4
	Per Share
	Basic EPS	6.87
	Diluted EPS	6.87
	Other Comprehensive Income — detail
	+ Other Comprehensive Income	1.0
	+ Items NOT to be Reclassified to P&L	1.3
	+ Tax on Items NOT to be Reclassified	0.3
	Comprehensive Income — Owners of Parent	259.0
	Comprehensive Income — Non-controlling Interests	15.5
	Per Share — as-filed variants
	Basic EPS — Continuing Operations	6.87
	Diluted EPS — Continuing Operations	6.87
	Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
	Gross Profit	1,383.6
	Gross Margin %	82.39
	Adjusted (ex-Exceptional Items) — derived
	Pretax Income (Adjusted, as filed)	354.6
	Net Income Adj (tax-effected)	273.6
	EPS Adj	6.87
	Other Filed Concepts — mapped but not yet placed in the schedule
	Face Value	2.00
	Paid Up Equity Capital	86.4

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.